NanoViricides
NNVC
#10581
Rank
A$44.74 M
Marketcap
A$1.75
Share price
-1.68%
Change (1 day)
-19.40%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): A-$0.67

According to NanoViricides's latest financial reports the company's current EPS (TTM) is A-$0.66. an increase over its 2025 EPS that were of A-$0.94.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026A-$0.61-34.92%
2025A-$0.94-10%
2024A-$1.05-5.41%
2023A-$1.115.71%
2022A-$1.05-13.58%
2021A-$1.21-66.11%
2020A-$3.581.7%
2019A-$3.52-10.98%
2018A-$3.95-22.35%
2017A-$5.09-10.53%
2016A-$5.69375%
2015A-$1.20-85.19%
2014A-$8.0842.11%
2013A-$5.6926.67%
2012A-$4.49-6.25%
2011A-$4.7914.28%
2010A-$4.19100%
2009A-$2.10-0%
2008A-$2.10-33.33%
2007A-$3.14-0%
2006A-$3.144445.07%
2005A-$0.06915

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
A-$4.64 604.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.49-325.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.76-1,127.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.31-753.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A-$2.27 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A-$2.02 206.82%๐Ÿ‡บ๐Ÿ‡ธ USA